Power Doppler breast ultrasound: Association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma

Breast Cancer

Volumn 20, Issue 2, 2013, Pages 152-158

  Chen, Shou Tung ^a   Kuo, Shou Jen ^a,b   Wu, Hwa Koon ^a   Chen, Li Sheng ^c   Chen, Dar Ren ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

c erbB 2; Estrogen receptor; Tumorigenesis; Vascularization

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CLINICAL FEATURE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION; TUMOR VOLUME; BREAST TUMOR; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; FOLLOW UP; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; TUMOR INVASION; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; ULTRASONOGRAPHY, DOPPLER;

EID: 84884808064     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-011-0317-y     Document Type: Article

References (20)

1. Hsiao YH, Huang YL, Liang WM, Lin C, Kuo SJ, Chen DR. Characterization of benign and malignant solid breast masses: harmonic versus nonharmonic 3D power Doppler imaging. Ultrasound Med Biol. 2009;35:353-9.
2. Kuo SJ, Hsiao YH, Huang YL, Chen DR. Classification of benign and malignant breast tumors using neural networks and three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol. 2008;32:97-102.
3. Carson PL, Moskalik AP, Govil A, Roubidoux MA, Fowlkes JB, Normolle D, et al. The 3D and 2D color flow display of breast masses. Ultrasound Med Biol. 1997;23:837-49. (Pubitemid 27349531)
4. Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B, et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol. 1997;151:1523-30. (Pubitemid 27527914)
5. Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, et al. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene. 2000;19:3460-9. (Pubitemid 30487443)
6. Vamesu S. Angiogenesis and c-erbB-2 (HER2/neu) overexpression status in primary breast cancer patients: an analysis of 158 needle core biopsies. Rom J Morphol Embryol. 2007;48:121-9.
7. Lee JE, Chung KW, Han W, Kim SW, Shin HJ, Bae JY, et al. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells. Anticancer Res. 2004;24:3961-4. (Pubitemid 40468693)
8. Lee CN, Cheng WF, Chen CA, Chu JS, Hsieh CY, Hsieh FJ. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels. Obstet Gynecol. 2000;96:615-21.
9. Yang WT, Tse GM, Lam PK, Metreweli C, Chang J. Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J Ultrasound Med. 2002;21:1227-35. (Pubitemid 35257572)
10. Jarvela IY, Sladkevicius P, Kelly S, Ojha K, Nargund G, Campbell S. Three-dimensional sonographic and power Doppler characterization of ovaries in late follicular phase. Ultrasound Obstet Gynecol. 2002;20:281-5.
11. Chang WC, Chang DY, Huang SC, Shih JC, Hsu WC, Chen SY, et al. Use of three-dimensional ultrasonography in the evaluation of uterine perfusion and healing after laparoscopic myomectomy. Fertil Steril. 2009;92:1110-5.
12. Pairleitner H, Steiner H, Hasenoehrl G, Staudach A. Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. Ultrasound Obstet Gynecol. 1999;14:139-43. (Pubitemid 29440656)
13. Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol. 2001;19:1207-25. (Pubitemid 32176299)
14. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-10.
15. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957;11:359-77.
16. Vogl G, Bartel H, Dietze O, Hauser-Kronberger C. HER2 is unlikely to be involved in directly regulating angiogenesis in human breast cancer. Appl Immunohistochem Mol Morphol. 2006;14:138-45. (Pubitemid 43941175)
17. Sullivan CA, Ghosh S, Ocal IT, Camp RL, Rimm DL, Chung GG. Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Hum Pathol. 2009;40:156-65.
18. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-64. (Pubitemid 26272076)
19. Menard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, et al. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res. 2002;8:520-5. (Pubitemid 34193972)
20. Folkman J. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.